Skip to main content
14 October 2026
14 October 2026

Cognito and Rhode Island Life Science Hub Establish Brain Health Platform

The Rhode Island Life Science Hub (RILSH) and Cognito Therapeutics announced the launch of the Rhode Island Brain Health Collaboratory, the third Collaboratory in Cognito's growing national network, following collaborations with the West Virginia University Rockefeller Neuroscience Institute in 2025 and Ochsner Health…

14 October 2026

Scinai Signs Major Development and Manufacturing Agreement with US Biopharma Firm

Scinai Immunotherapeutics Ltd., a biopharmaceutical company operating a growing contract development and manufacturing organization ("CDMO") alongside an immunology-focused therapeutic development platform, announced that its wholly owned subsidiary, Scinai Biopharma Services Ltd., has entered into a definitive develo…

12 October 2026

LOTTE Biologics Partners with Alvotech on Biologics Manufacturing

LOTTE Biologics, a contract development and manufacturing (CDMO) organization, and Alvotech, a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced a long-term strategic manufacturing partnership. Under the agreement, LOTTE Biologics wi…

09 October 2026

SOPHiA GENETICS, Myriad Partner on Precision Prostate Cancer Diagnostics

SOPHiA GENETICSand Myriad Genetics, Inc. announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca. PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous re…

09 October 2026

Viatris to Acquire Pacira BioSciences for $1.65 Billion

Viatris Inc., a global healthcare company, and Pacira BioSciences, Inc., a leader in innovative non-opioid pain therapies,  announced that they have entered into a definitive agreement under which Viatris has agreed to acquire all of the outstanding shares of common stock of Pacira for $36.50 per share in cash, repres…

08 October 2026

10x Genomics Advances Oncology Research with Fred Hutch

10x Genomics, Inc., the life science technology leader focused on accelerating science and advancing human health,  announced a multi-project research collaboration with Fred Hutchinson Cancer Center (Fred Hutch), one of the nation's leading cancer research institutions, to advance the use of single cell and spatial t…

08 October 2026

AmyriAD Acquires Recognify to Expand Cognition Drug Pipeline

AmyriAD Therapeutics B.V., a clinical-stage biopharmaceutical company focused on cognition in central nervous system disorders, announced the acquisition of Recognify Life Sciences, Inc. and its lead clinical-stage program, RL-007 (inidascamine). The acquisition expands AmyriAD's cognition pipeline while preserving Is…

07 October 2026

Birmingham Promise, AIR Partner to Strengthen Career Pathways

Birmingham Promise and the American Institutes for Research (AIR) have launched a new partnership to strengthen how student data are used to understand and support young people as they move from high school to college and careers. Birmingham Promise grew out of an initiative launched under Mayor Randall Woodfin's adm…

Page 1 of 41

slot gacor